Publications by authors named "Andrey Baranovsky"

Claim this Profile
C
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
Séverine Vermeire, Stefan Schreiber, Robert Petryka, Tanja Kuehbacher, Xavier Hebuterne, Andrey Baranovsky

Lancet· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
Don C Rockey, John M Vierling, Parvez Mantry, Marwan Ghabril, Robert S Brown, Andrey Baranovsky

Hepatology· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Tilo Andus, Andreas Kocjan, Moritz Müser, Andrey Baranovsky, Tatyana L Mikhailova

Inflamm Bowel Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis